Program Chair
-
Prof. Dr. Gerhard Hindricks
Berlin
6.-7.11.2026
i-LAB
Oranienburger Str. 35
10117 Berlin
Discover how AI is transforming risk management in atrial fibrillation, heart failure and other cardiac diseases — not only by predicting critical events earlier and preventing deterioration through intelligent insights, but also by uncovering hidden patterns that were previously invisible to clinicians. These new layers of understanding open the door to unprecedented predictive capabilities and truly personalized treatment pathways. See why artificial intelligence is becoming the new backbone of proactive, precise, and patient‑centered cardiac care.
Join us at the DHS and immerse yourself in the fascinating world of digital and AI‑driven innovations in cardiology.
We look forward to welcoming you to this year’s DHS under the motto:
Predict. Prevent. Personalize: AI as the New Backbone of Cardiac Risk Management
The way we communicate and how patients are cared for has changed significantly in recent years. With a new event series – DIGITAL HEART SUMMIT – we aim to highlight digital trends and developments in cardiology and discuss innovative concepts for improving care. In keeping with the current zeitgeist, we will bring together users, decision-makers, and patients from around the world, either virtually or in person, to actively shape the cardiology of the future.
BIOTRONIK Connects Global Experts to Drive Digital Transformation in Cardiology
At the Digital Heart Summit 2025 in Berlin, 120 leading experts gathered to explore how digital innovation is reshaping cardiovascular care. Organized by BIOTRONIK, the event spotlighted the growing impact of artificial intelligence, real-world data, and patient-centric technologies in redefining diagnostics and treatment strategies.
Discussions highlighted how digital tools are moving toward proactive, preventive care. For the experts, the vision is clear: by integrating AI-driven insights with patient engagement strategies, connected platforms can support informed decision-making across regions and specialties. This shift moves the focus from managing disease to maintaining long-term heart health.
“The combination of AI-driven data and a strong focus on patient empowerment is a key driver of digital transformation in cardiology,” said Prof. Gerhard Hindricks, Department of Cardiology, Angiology and Intensive Care Medicine and Chief Integration Officer at Deutsches Herzzentrum der Charité and chair of the summit. “Our goal must be to create holistic and smart solutions that support prevention and enable both physicians and patients to make evidence-based decisions.”
Adding to this perspective, Dr. Marco Perez, Associate Professor of Medicine at Stanford University and panelist at the event, emphasized the transformative role of advanced algorithms: “Machine learning and large language models are opening new frontiers in the diagnosis and management of atrial fibrillation. By leveraging these technologies, we can identify patterns earlier, personalize treatment, and ultimately improve patient outcomes on a global scale.”
BIOTRONIK showcased its successful implementation of eHealth solutions across multiple markets. In Germany, over 12,000 patients benefit from the inCareNet HF platform, making BIOTRONIK the market leader in digital heart failure care.
The experts explored scalable remote monitoring, digital reimbursement models, and real-world evidence. Studies such as the HERMeS trial demonstrated how digital tools can improve outcomes and streamline care. The participants also tested next-generation sensors, remote device management, and connected platforms.
Despite technological progress, regulatory complexity, fragmented infrastructures, and reimbursement hurdles remain significant barriers to adoption. Successful projects in Europe, Australia, and the US offered roadmaps for overcoming these barriers. “The Digital Heart Summit highlighted the need for innovative solutions in telecardiology. The ideas shared will help shape the future of cardiac care and accelerate eHealth adoption,” concluded Dr. Andreas Hecker, Chief Technology Officer at BIOTRONIK.
-END-
i-LAB
Oranienburger Str. 35
10117 Berlin
52°31'30.5"N 13°23'34.0"E